Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Lymphoma, Follicular × Capecitabine × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Stomach Neoplasms 3 Neoplasms 2 Neoplasm Metastasis 2 Rectal Neoplasms 1 Rectal Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Intestinal Neoplasms 1 Intestinal Diseases 1 HER2+ Metastatic Breast Cancer (MBC) 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Colonic Diseases 1 Brain Neoplasms 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

Rituximab 5 Lenalidomide 3 fludarabine 2 Cyclophosphamide 2 zanubrutinib 1 venetoclax 1 umbralisib 1 ublituximab 1 tisagenlecleucel 1 tazemetostat 1 tafasitamab 1 prednisolone phosphate 1 prednisolone acetate 1 pirtobrutinib 1 obinutuzumab 1 duvelisib 1 axicabtagene ciloleucel 1 Prednisolone 1 Methylprednisolone 1 Bendamustine Hydrochloride 1 Appointments and Schedules 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡